{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:39:59Z","timestamp":1769607599068,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.bbamcr.2016.04.019","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T05:25:13Z","timestamp":1462080313000},"page":"1969-1978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Integrin \u03b1v\u03b23 expression in tongue squamous carcinoma cells Cal27 confers anticancer drug resistance through loss of pSrc(Y418)"],"prefix":"10.1016","volume":"1863","author":[{"given":"Nikolina","family":"Stojanovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamaria","family":"Brozovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragomira","family":"Majhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja Herak","family":"Bosnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Osmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreja","family":"Ambriovi\u0107-Ristov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2016.04.019_bb0005","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI61350","article-title":"Beta(1)Integrin\/FAK\/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy","volume":"122","author":"Eke","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2012.05.009","article-title":"Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by beta1 integrin inhibition","volume":"104","author":"Eke","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/mol.107.043836","article-title":"Alpha(v)beta(3) integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species","volume":"74","author":"Brozovic","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbamcr.2016.04.019_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","article-title":"Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance","volume":"25","author":"Seguin","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0030","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/00006676-200208000-00021","article-title":"Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis","volume":"25","author":"Hosotani","year":"2002","journal-title":"Pancreas"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0035","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1038\/sj.onc.1210429","article-title":"Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling","volume":"26","author":"McCabe","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0040","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1073\/pnas.98.4.1853","article-title":"Integrin activation controls metastasis in human breast cancer","volume":"98","author":"Felding-Habermann","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.bjc.6602278","article-title":"Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapy","volume":"92","author":"Gruber","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2559.1994.tb00517.x","article-title":"Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression","volume":"24","author":"Danen","year":"1994","journal-title":"Histopathology"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2005.12.004","article-title":"Integrin-mediated cell-matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury","volume":"242","author":"Cordes","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0060","doi-asserted-by":"crossref","first-page":"27757","DOI":"10.1074\/jbc.M102014200","article-title":"A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription","volume":"276","author":"Matter","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0065","first-page":"660","article-title":"Increased adenoviral transduction efficacy in human laryngeal carcinoma cells resistant to cisplatin is associated with increased expression of integrin alphavbeta3 and coxsackie adenovirus receptor","volume":"110","author":"Ambriovic-Ristov","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.200106070","article-title":"Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins","volume":"155","author":"Stupack","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1242\/jcs.018093","article-title":"Integrin signalling at a glance","volume":"122","author":"Harburger","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.lfs.2011.06.009","article-title":"Increased expression of the coxsackie and adenovirus receptor downregulates alphavbeta3 and alphavbeta5 integrin expression and reduces cell adhesion and migration","volume":"89","author":"Majhen","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0085","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0021-9258(17)31269-3","article-title":"Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit","volume":"264","author":"Heino","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0090","doi-asserted-by":"crossref","first-page":"17409","DOI":"10.1016\/S0021-9258(18)41941-2","article-title":"Transforming growth factor beta differentially regulates expression of integrin subunits in guinea pig airway epithelial cells","volume":"267","author":"Sheppard","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal adhesion kinase: in command and control of cell motility","volume":"6","author":"Mitra","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0100","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/MCB.14.3.1680","article-title":"Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src","volume":"14","author":"Schaller","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0105","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0110","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1038\/onc.2011.177","article-title":"Integrin-linked kinase: not so \u2018pseudo\u2019 after all","volume":"30","author":"Hannigan","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose\u2013effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","article-title":"Integrin signalling during tumour progression","volume":"5","author":"Guo","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0165-7992(93)90023-O","article-title":"Resistance of human larynx carcinoma cells to cisplatin, gamma-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes","volume":"303","author":"Osmak","year":"1993","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/138945011794751591","article-title":"Dasatinib: an anti-tumour agent via Src inhibition","volume":"12","author":"Gnoni","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0135","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.18632\/oncotarget.3071","article-title":"Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas","volume":"6","author":"Veracini","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0140","doi-asserted-by":"crossref","first-page":"158","DOI":"10.18632\/oncoscience.20","article-title":"Predictive biomarkers for dasatinib treatment in melanoma","volume":"1","author":"Eustace","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0145","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1158\/1535-7163.MCT-09-0151","article-title":"Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin","volume":"8","author":"Ceppi","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0150","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1038\/onc.2008.326","article-title":"Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling","volume":"27","author":"Ischenko","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0155","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1124\/mol.108.051649","article-title":"Cross-talk between integrins and oncogenes modulates chemosensitivity","volume":"75","author":"Puigvert","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0160","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/bjc.2014.432","article-title":"Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours","volume":"111","author":"Baro","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0165","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1158\/0008-5472.CAN-08-2944","article-title":"Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding","volume":"69","author":"Sen","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0170","first-page":"1587","article-title":"Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death","volume":"5","author":"Uhm","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0175","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1158\/0008-5472.CAN-08-2524","article-title":"Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0180","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.onc.1208238","article-title":"A novel CYR61-triggered \u2018CYR61-alphavbeta3 integrin loop\u2019 regulates breast cancer cell survival and chemosensitivity through activation of ERK1\/ERK2 MAPK signaling pathway","volume":"24","author":"Menendez","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.febslet.2014.12.004","article-title":"Osteopontin-integrin alpha(v)beta(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma","volume":"589","author":"Nakamura","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0190","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3892\/ijo.2014.2265","article-title":"Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells","volume":"44","author":"Nakagawa","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0195","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/jnci\/djt263","article-title":"Combating resistance to anti-IGFR antibody by targeting the integrin beta3-Src pathway","volume":"105","author":"Shin","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbamcr.2016.04.019_bb0200","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/sj.onc.1206347","article-title":"Alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells","volume":"22","author":"Cruet-Hennequart","year":"2003","journal-title":"Oncogene"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488916301197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488916301197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T13:29:53Z","timestamp":1655645393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488916301197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0167488916301197"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2016.04.019","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrin \u03b1v\u03b23 expression in tongue squamous carcinoma cells Cal27 confers anticancer drug resistance through loss of pSrc(Y418)","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2016.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}